ROKIT Healthcare provides hardware, software, and application support. Their custom fabrication technologies deliver solutions to the design, creation, and applications of three-dimensional systems. They provide suffering patients and humans with a hyper-personalized medical organ regeneration solution. They apply artificial intelligence and 3d bioprinting technology to regenerate the skin and cartilage organs through surgery for patients.

Gid Bio Inc. is a company headquartered in Louisville, CO, that provides cellular therapy based treatments for osteoarthritis of the knee. It was founded in 2010 by G. Patrick Maxwell, J. William Futrell, Adam J. Katz and Ramon Llull. William W. Cimino is currently the CEO of the firm.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Develops and markets autologous cell-based therapeutics for use in regenerative medicine

Arthrex GmbH, a subsidiary of Arthrex, Inc., is a German company located in Munich that manufactures orthopedic devices. Stefan Krupp is currently the CEO of the firm.

Stempeutics Research Pvt. Ltd. is a private company headquartered in Bangalore, India. The firm develops, commercializes and sells novel therapeutics products.\nThe company says this about itself: Stempeutics Research Bangalore is a late stage life science company focused on developing and commercializing novel therapeutics based on adult stem cells. It was founded by the Manipal Education and Medical Group in 2006. Stempeutics strength lies in developing innovative stem cell products by nurturing cutting edge research and clinical applications through dedicated efforts of its highly qualified team. Currently it is focusing on the following three innovative products: Stempeucel® drug, Stempeucare™ cosmetics and Stempeutron™ medical device.

CG Bio Co., Ltd. is a private company headquartered in Seongnam, the South Korea, with subsidiaries in that country, specializing in surgical and medical instruments and apparatus. It was founded in 2006. Hyun-Seung Yoo is currently the CEO of the firm.

SynGen enables regenerative cures through innovative engineering. The company invents and commercializes products that utilize single-use sterile plastic cartridge disposables mated to dedicated, highly automated electromechanical medical devices to isolate and capture stem and progenitor cells from peripheral and umbilical cord blood, bone marrow, and adipose tissue. Their products provide an important enabling platform for use in diagnostic, research, and clinical processes. Their inventions are based upon interdisciplinary fields that apply principles of engineering and life sciences to develop solutions required for regenerative medicine.

Cellular Biomedicine Group (Shanghai) Ltd. engages in development and sales of laboratory equipment and consumables, biological reagents. The company was founded on October 19, 2011 and is headquartered in Shanghai, China.

Arteriocyte Medical Systems, Inc. is a leading medical device company dedicated to helping patients heal faster by developing innovative solutions to improve the outcomes of surgical procedures based on cell and tissue based therapies. The Company’s lead product is the Magellan® Autologous Platelet Separator. The Magellan® System provides surgeons the ability to fractionate peripheral blood and/or aspirated bone marrow from a patient, for that patient, at bedside in approximately 15 minutes using a fully automated closed loop separation process. The Magellan® device yields a 3-10cc injectable unit of platelet and stem cell enriched plasma for the surgeon’s use in his or her procedure.

AdipoSeeds, though a novel technology, creates platelets from mesenchymal stem cells without a complex and costly gene transfer. It aims to invent new blood supply system to solve the shortage of platelets in the world, and to create a future where a platelet-related treatment will be cheaply and safely provided.

Guangzhou Saliai Stemcell Science & Technology Co., Ltd. engages in the provision of stem cell storage, health supplements, biological products, and related health management services. It involves in the production of regenerative medicine devices, medical nutrition supplements, and biological & medical cosmetic products. It operates a research and development platform which includes life bank, health management center, medical center, and medical cell center. The company was founded by Hai Jia Chen and Ming Jia Chen on July 7, 2009 and is headquartered in Guangzhou, China.

IntelliCell BioSciences, Inc. operates as a regenerative medicine company. Its proprietary patent pending process involves the application of ultrasonic cavitation (sound waves) to the extracted adipose tissue for the separation of adult autologous vascular cells (AAVC’s) from the blood vessels in adult adipose (fat) tissue. These AAVC’s or stromal vascular fraction are a heterogeneous mixture of regenerative cells and autologous adult stem cells that promote the healing of injured tissue. AAVC’s contain adult stem cells, fibroblasts, growth factors, and other cellular components. The company plans to focus on regenerative medicine in the areas of aesthetics, orthopedics, sports medicine, pain management, and periodontal diseases. IntelliCell BioSciences, Inc. also licenses its technologies in Canada, Australia, New Zealand, Thailand, and the United States. The company is based in New York, New York.

Antria, Inc. operates as a clinical research organization that specializes in the development of regenerative medicine and cellular therapies for the treatment of diverse diseases. The company also provides its services to biotechnology companies and the research industry. It applies autologous adult stem cells and platelet rich plasma technologies to discern, detect, and prevent illnesses in a myriad of medical specialties. The company’s research pipeline spans multiple medical disciplines and specialties, including cosmetic and reconstructive surgery, neurology, cardiology, orthopedics, and internal medicine; and chronic and non healing wounds, breast cancer and augmentation, multiple scle...

Cellular Biomedicine Group (Wuxi) Ltd., a subsidiary of Cellular Biomedicine Group, Inc., is a company headquartered in China that engages in the development of effective treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies.

Gachon University Gil Medical Center is a South Korean private company. The firm operates as medical center.

Flex Partners, Inc. designs and develops medical devices and instruments. It provides devices used for urological, cardiovascular, orthopedic, oral, and plastic surgical procedures. The firm's services include product prototyping, simulations and product testing, intellectual property development, validation and verification, program management, and business development. The company was founded in 1980 and is headquartered in Solana Beach, CA.

Akan Biosciences LLC is a private company headquartered in Germantown, MD. The firm operates as a biotechnology and cellular therapy company which develops regenerative medical therapeutics.\nThe company says this about itself: Akan Biosciences, LLC (Akan), a Maryland based, clinical stage biotech company innovating cellular technology and proprietary manufacturing methods to produce stem cell-based therapeutics. Akan is focused on advancing next generation therapies for degenerative diseases and injury. Akan is part of the Maryland Tech Council and Biohealth Innovation, Inc..